A new weight loss injection called retatrutide has shown remarkable results in helping users shed weight quickly. However, ...

While potential U.S. tariffs on Canadian imports will likely increase its supply costs, U.S. fuel distributor and retailer Global Partners' chief executive said they will not affect the company's ...

Insurer cites "significantly higher medical utilization with an expensive health care system, along with skyrocketing ...

Demi Moore, Nicole Kidman and Mindy Kaling are among the stars who stepped out with slimmed-down figures during awards season, a trend that one expert says could be due to a "combination of factors." ...

Blue Cross Blue Shield of Michigan reported a hefty $1.03 billion loss in 2024 as rising costs in the sector batter the health insurer's bottom line in “unsustainable” market conditions.

Hims & Hers Health (NYSE:HIMS) experienced a 40% increase in share price last quarter, possibly fueled by strong financial performance and future growth projections. The company announced earnings on ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...

Anti-obesity GLP-1 medications aren't as effective as bariatric surgery for weight loss and improving obesity-related conditions ...

As consumers who use GLP-1 drugs seek lean, protein-rich foods, the demand for ground turkey has been increasing.

Blue Cross Blue Shield of Massachusetts (BCBSMA), the state's largest health insurer, ended 2024 with a staggering $400.4 ...

Discover why Hims & Hers faces steep corrections amid GLP-1 headwinds and valuation concerns, despite promising FY2024 growth ...

AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire global rights to GUB014295, a ...